Search results
At the heart of our operation lies a dynamic R&D nucleus. Our accomplished team, comprising leading scientists and experienced chemists, propels advanced research and innovation. Boasting a formidable cadre of 60 R&D scientists, alongside 65 analytical experts, we forge a pathway to progress.
Pure Play API Manufacturer with 2 API site, 3 R&D and 2 Int associate site delivering compliant and competitive API | Established in 2017, We are a pure-play Active Pharmaceutical Ingredient...
Aurore Life Sciences is a pure-play API and intermediates manufacturer with a robust product portfolio of 40+ commercially produced APIs across a wide range of therapeutic categories.
From early-stage development and process optimization to large-scale commercial manufacturing, Aurore Life Sciences offers a comprehensive suite of services. Our expertise covers a wide range of therapeutic areas, enabling us to contribute to advancements in healthcare across various domains.
Apr 11, 2021 · The Board of Directors of Solara Active Pharma Sciences accepted the recommendations of the Committee of Independent Directors and Audit Committee and approved the amalgamation of Aurore, Empyrean and Hydra with Solara.
Apr 11, 2021 · With this merger, Aurore Life Science Private Limited, Empyrean Lifesciences Private Limited and Hydra Active Pharma Sciences Private Limited shall be merged into Solara Active Pharma...
Jul 8, 2021 · The recent acquisition of Aurore Life Sciences strengthened the company’s active pharmaceutical ingredient (API) and Contract Research & Manufacturing Services (CRAMS) portfolio. Plant utilization of phase-I of the Vizag facility has been ramped up in the last year.
